M-A: Interventions to prevent bronchopulmonary dysplasia in preterm neonates.

Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses – JAMA Pediatrics (link to abstract – $ for full-text)

Related:

RCT: In preterm infants with respiratory distress syndrome, surfactant administration via a thin catheter did not improve outcomes.

Systematic Review: Late (after 6 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Systematic Review: Early (started within six days) systemic postnatal corticosteroids for preventing bronchopulmonary dysplasia in preterm infants.

State of the Art Review: Diagnosis and management of bronchopulmonary dysplasia.

Systematic Review: Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome is associated with reduced risk of death or bronchopulmonary dysplasia, less intubation in the first 72 hours, and reduced incidence of major complications and in‐hospital mortality.

ERS Guideline on Long-term Management of Children with Bronchopulmonary Dysplasia

Randomized Trial: Sustained Inflations vs Intermittent Positive Pressure Ventilation in Extremely Preterm Infants

Randomized Trial: Effect of Hydrocortisone on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation

Research: Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia

Commentary on Twitter

A meta-analysis in @JAMAPeds evaluates interventions that may prevent BPD https://t.co/871W5OaNAC #EBNEOalerts #neoEBM #neotwitter pic.twitter.com/UXfYhQU3wd

— Evidence-Based Neo (@EBNEO) March 9, 2022